An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Zhejiang University
Zhejiang University
Jonsson Comprehensive Cancer Center
University of South Florida
Mayo Clinic
Mayo Clinic
Beijing Kejing Biotechnology Co., Ltd.
OHSU Knight Cancer Institute
Mainline Biosciences, Inc.
Shanghai Yunying Medical Technology
National Institutes of Health Clinical Center (CC)